Science & Technology
Phase I Therapeutic Award: Chimeric Nanoparticle Delivery of an Sarna-Based Cancer Vaccine for Familial Adenomatous Polyposis
Department of Health and Human Services — National Institutes of Health
Opportunity #: 75N91024C00011
Award Ceiling
$300K
Award Floor
$300K
Close Date
N/A
Total Funding
$300K
Expected Awards
1
Cost Sharing Required
No
Grants.gov ID
sbir-75N91024C00011
Description
SBIR Phase Phase I award: "PHASE I THERAPEUTIC AWARD: CHIMERIC NANOPARTICLE DELIVERY OF AN SARNA-BASED CANCER VACCINE FOR FAMILIAL ADENOMATOUS POLYPOSIS" awarded to CHIMERON BIO CORPORATION in PHILADELPHIA, Pennsylvania. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $300,000. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.